Blog Archive

Who's Here

source: The Irish Times

SEANAD REPORT: THE STATE faces a potential swine flu pandemic, Liam Twomey (FG) warned. Anyone who did only a small amount of research would realise that the HSE’s campaign in regard to the swine flu vaccination programme was an absolute shambles and was falling apart. 

There were not l,800 doctors participating in the scheme. The HSE had been sending vaccine doses to general practitioners’ surgeries, but no documentation whatsoever had been sent. 

There was a serious need for the Minister for Health to actually say that she was responsible for something and she should look into what was going on “with this potential pandemic in our healthcare system. Because at this moment in time my gut instinct is that it is a mess."

Lisa McDonald (FF) said there was an urgent need for clarification on the availability of the vaccine for pregnant women. She had been contacted by a woman who lived next door to someone who had been stricken by the virus.

This woman, who was 32 weeks pregnant, had been told by her GP that he would not be providing the “vaccination”. It was a disgrace that they were allowing vulnerable people to endure worry because of a lack of clarification which could, in her view, be provided quickly.

A Fine Gael move to have an emergency debate on how the December 9th budget should be framed, was defeated by a single vote – 25 to 24.

Dan Boyle (Green Party), deputy Government leader in the House, said he did not think any Senator should second guess what was likely to happen on December 9th. The Government was committed to a budget adjustment of €4 billion.

The circumstances demanded that such an adjustment be made, but how this was to be done had yet to be decided, added Mr Boyle.

| edit post

source: The Belfast Telegraph

The safety of Northern Ireland’s swine flu vaccination programme was called into question today by the parent of a young special needs pupil who ended up in hospital just hours after getting the jab.

Anne Marie Fletcher said she feared her 15-year-old son Rhys was going to die as she rushed him to hospital less than 24 hours after receiving the swine flu vaccine.

The teenager fell seriously ill after receiving the injection, along with thousands of other pupils across Northern Ireland last Friday. He was later diagnosed with swine flu

“My husband drove us to Antrim (Area Hospital) and I sat in the back with Rhys,” she told the Belfast Telegraph.

“By this stage he was going into spasms. He couldn’t bend his fingers. I was absolutely terrified.

“He was rambling and becoming incoherent. I honestly thought he was going to die in the back of the car.

“He kept saying he wanted to sleep but I wouldn’t dare let him close his eyes because I was frightened that if I did he would never wake up.”

The Public Health Agency, the organisation tasked with managing Northern Ireland’s response to the swine flu pandemic, has stated clearly that anyone suffering from flu-like symptoms should remain at home and contact their GP by telephone.

The experience of the Fletcher family from Carrickfergus calls into question whether Government protocols regarding the handling of swine flu are being followed. It is the latest episode to shake public confidence after the family of a Londonderry teenager who died with the virus was not informed she had it until after her funeral.

Some 2,500 children in over 20 special schools for severe learning disability across Northern Ireland were offered the vaccine last week after four pupils died with the virus this month.

The Fletcher family’s ordeal began on Friday, several hours after 15-year-old Rhys received the swine flu vaccine at Hillcroft Special School in Newtownabbey.

“I was concerned about Rhys having the vaccination but after what I heard about the four children with special needs dying after contracting swine flu I thought it was better to be safe than sorry,” Mrs Fletcher said.

“I took him into school on Friday and he had his injection. A few hours later he started complaining of having a sore arm. He also had a temperature and he was starting to cough. During the night he started to complain that he felt sick. He was up and down most of the night retching.”

Mrs Fletcher contacted the out-of-hours GP service and was told to bring Rhys to Whiteabbey Hospital. She expressed concerns about bringing him to a hospital in light of his symptoms.

“He was in a lot of discomfort and a lot of pain. He was surrounded by people and they were objecting about him being in the waiting area. When we were eventually seen we were told he had to be referred to Antrim Area Hospital.

“My husband drove us to Antrim and I sat in the back with Rhys. By this stage he was going into spasms. He couldn’t bend his fingers, I was absolutely terrified. He was rambling and becoming incoherent. I honestly thought he was going to die in the back of the car.

“He kept saying he wanted to sleep but I wouldn’t dare let him close his eyes because I was frightened that if I did he would never wake up.”

Following treatment at Antrim Area Hospital the teenager’s condition improved enough for him to be discharged, but several hours after returning home the family received a telephone call from the Public Health Agency.

“They mentioned that Rhys may have swine flu when he was in Antrim Hospital but then they said he didn’t have it and he was probably suffering from a reaction from the injection, although they said they couldn’t be sure,” continued Mrs Fletcher.

“We took Rhys home and just before 11pm we got a call from a doctor with the Public Health Agency who wanted to discuss Rhys’ symptoms. They phoned again about 11.10pm and asked me to bring Rhys to Dalriada (out of hours GP) to be tested for swine flu, but I told them I wasn’t taking him anywhere at that time of night.

“They phoned back later and said there was no urgency and we could bring in the morning, but I refused. I told them I thought people with suspected swine flu shouldn’t be taken to hospital and they said it was OK because they could see him in a private room.

“I was disgusted at this point and said I wouldn’t bring Rhys to hospital, so eventually a district nurse came out on Sunday to take some swabs. We got a phone call later on to say he had swine flu.”

Mrs Fletcher said she was horrified at the treatment her son has received and that she has serious concerns that countless other people have been exposed to the virus as a result.

“Rhys is still very listless and I’m worried he could become badly affected by the swine flu. He is on Tamiflu now but I’m also worried he could suffer side-effects from that as well.”

The Department of Health said it could not comment on operational matters, while the Public Health Agency did not provide a response.

A spokesman from the Northern Health Trust said: “We appreciate that this issue was brought to our attention. We cannot discuss individual cases but there is an agreed protocol for dealing with cases such as this. A number of agencies were involved and clearly the protocol was not followed as it should have been.

“We appreciate the concerns that this will have caused and we will examine the circumstances with our partner organisations to make sure this does not happen again.”

Meanwhile, the Health Minister has announced that the swine flu vaccination is to be offered to staff who provide personal care for pupils at special schools here.

The vaccination programme for children with complex special needs was carried out last week.

“The staff who provide personal care to the vulnerable children within special schools for severe learning disability are doing similar work as frontline health and social care workers. Therefore I believe that this move will further protect this vulnerable group of children and young people. I have asked the Public Health Agency to make arrangements to offer vaccine to this group of staff as quickly as possible,” Michael McGimpsey said.

| edit post

Swine Flu Peaks Out

Posted by ObeMike 0 comments

source: NatrualNews

Swine flu peaks out before vaccines even make it into widespread distribution

Swine flu infections have peaked out in the USA, even before drug companies could get their vaccines injected into everyone. According to CDC findings announced recently in Atlanta, one in five U.S. children have already experienced the flu this month, and most of those were likely H1N1 swine flu cases, the CDC says.

This comes from a survey of over 10,000 U.S. households conducted by the CDC.

Meanwhile, flu vaccine shipments are way behind schedule. There have been supply problems from the start, and as of right now, relatively few Americans have yet been injected with the swine flu vaccine. (Many have stood in line for hours trying to be injected, but were told to go home with the vaccine ran out.)

Out of nearly 14,000 suspected flu cases tested during the week ending on October 10, 2009, 99.6% of those were influenza A, and the vast majority of those were H1N1 swine flu infections. ( This is a very strong indication that swine flu infections have peaked during October, 2009.

Further supporting that notion, researchers from Purdue University just published a paper in the October 15 issue of Eurosurveillance (a science journal about communicable disease) in which researchers stated that the H1N1 swine flu epidemic would peak during "week 42" (the end of October). Week 42 just passed. It's over.

The AJC is also reporting this week that swine flu is "retreating" in Georgia, where hospital visits from the flu are markedly down and fewer illnesses are being reported in schools, too.

Even the WHO is reporting a downward trend in many areas, saying, "In tropical areas of the world, rates of illness are generally declining, with a few exceptions. ...In tropical Asia, of the countries that are reporting this week, all report decreases in respiratory disease activity."

Meanwhile, even as the swine flu infection peaks out, the shortage of swine flu vaccines means few people have yet been vaccinated. The shortage is causing "chaos" in clinics across the country, news reports say, and flu vaccination events have been cancelled due to the non-arrival of expected vaccines.

And what, exactly, is causing this shortage of vaccines? According to Health and Human Services Secretary Kathleen Sebelius, they're being caused by "production failures" at the drug manufacturing facilities.

Too little, too late
Is she serious? People are lining up to be injected with chemicals made by companies that are suffering "production failures?" If these companies can't meet the production targets they already promised, how can we expect them to meet the safety targets they promised?

The bigger point, though, is that by the time vaccines are available for everyone, most people will have already been exposed to the H1N1 virus and therefore won't even need a vaccine. There's also evidence that previous exposure to seasonal flu may confer some natural immunity to H1N1, meaning that vaccines may be redundant from the start.

Delivering vaccines to the public after the pandemic peaks and wanes is sort of like putting on your seatbelt after a head-on collision. (This metaphor assumes, just for the moment, that swine flu vaccines actually work. Even though they don't.)

Through the coming holiday season, we'll all get to watch the CDC, the FDA and drug companies desperately try to push vaccines onto people, most of whom are already immune to H1N1 because they were exposed during the peak of the pandemic. This will be quite entertaining to observe because you'll get to watch health authorities in action, attempting to fabricate an emergency when the pandemic threat has already faded. To maximize vaccinations (and therefore Big Pharma revenues), they'll need to keep pushing the pandemic fears through the winter months while hoping that no one notices the H1N1 pandemic has evaporated.

Predictably, the big push at that point will be based on the following logic: "Even if you were already exposed to H1N1, getting a vaccine shot can't hurt. Might as well get one!"

The CDC, which once promised 150 million vaccines by mid-October has pushed its prediction to year's end. Unless some new H1N1 mutation is released into the population by some bioterrorist group, it's fairly obvious that the swine flu will have fizzled out by the time Christmas rolls around.

How to dispose of a hundred million doses of a useless vaccine...
So what will all these clinics do with all the millions of doses of vaccines that nobody really needs at that point? It might seem prudent to dump them down the river, except for the fact that their chemical additives and preservatives make many vaccines qualify as "hazardous waste" according to EPA regulations. It's illegal to toss them into rivers or even dump them down the drain... it's perfectly legal, though, to inject them into the body of a six-year-old.

Why don't they just save the vaccines for next year? They'll be useless, of course, but no more useless than they already are this year. Just save up all the vials and unleash another swine flu scare next fall to get rid of the inventory! (Don't laugh. These people might actually take the idea seriously...)

You gotta love the pharmaceutical industry. After forty years of research into cancer (and tens of billions of dollars spent on it), they have yet to find a cure for any cancer at all. And with the swine flu fiasco, they almost managed to come up with a vaccine, but the human immune system -- combined with a nation full of sneezers and spreaders -- beat them to it.

It must really be depressing to wake up one day as a pharmaceutical company executive and realize you're irrelevant... and that your "lifesaving" products are obsolete before they even hit the streets. Of course, the ridiculously high pay might make up for some of that, and if you get really depressed, you can always take your own company's pills if you're willing to brave the suicide risk. But in the end, the simple fact is that human beings would be better off of the drug companies didn't exist.

The fact that H1N1 swine flu has already peaked out before the bulk of the vaccine shipments have even arrived proves, once again, how utterly pathetic and medically useless flu vaccines are in the first place. There is nothing a flu vaccine can do that simple vitamin D can't do better, and the sad truth is that the entire flu vaccine industry is built on medical quackery and marketing propaganda.

| edit post

source: theflucase 

Citing a shortage of the vaccine, the state Department of Health has ended a mandate that most of the state's health care workers be inoculated against the flu.

Gov. David Paterson attributed Thursday's decision to limited supplies of the H1N1 vaccinations, a number of doses far short of the federal government's expected delivery. The decision also tosses out mandated seasonal flu shots. 

"Over the last week, the Centers for Disease Control and Prevention acknowledged that New York would only receive approximately 23 percent of its anticipated vaccine supply by the end of the month," Paterson said in a prepared statement. "As a result, we need to be as resourceful as we can with the limited supplies of vaccine currently coming into the state and make sure that those who are at the highest risk for complications from the H1N1 flu receive the first vaccine being distributed right now in New York state." 

This summer, the federal government projected 120 million doses would be available by the end of October. This week, the CDC changed expected delivery to just 27.7 million doses. The CDC allowed the state to order only 146,300 doses of vaccine, even though New York's health providers requested more than 1,482,822 doses.

The order from Health Commissioner Richard Daines that health care workers who come in contact with patients, including employees of hospitals, receive the vaccine came earlier this fall and has resulted in at least two lawsuits and protests over what many workers claimed was an unfair intrusion on their freedom of choice.

Daines presented the measure as a simple matter of due diligence for health care workers, whose presence in hospitals and other facilities brought them into close contact with infants, the elderly and other people whose immune systems might be compromised.

Daines said Thursday that it was essential to first get the vaccine to those who need it most.

"We had told hospitals that if they had to choose between vaccinating patients or employees to vaccinate patients first," Daines said in a prepared statement. "This week, the CDC confirmed that most of the national supply of seasonal flu vaccine has been distributed, and that H1N1 vaccine distribution is far behind projections. New evidence is showing that H1N1 can be especially virulent to pregnant women and young people – so they should get vaccinated first."

One of the lawsuits led to a temporary injunction against the order, which mandated that all health care workers get the shot by Nov. 30 or risk losing their jobs.

Opponents of the mandatory shots said they were heartened by the news.

"They should" withdraw the mandate, said Kevin McCashion upon hearing the news. The Colonie businessman helped organize a local protest against the mandate.

Lorna Patterson, a nurse in the emergency room at Albany Medical Center Hospital, was among a group of health care workers who brought a lawsuit to fight the order. She said late Thursday that she and her fellow nurses were just excited they could concentrate on nursing. She said Paterson recognized the importance of letting people make their own health care decisions.

"I'm just glad our health care organizations can function, knowing they have the stuff they need," she said.

Terence Kindlon, the Albany attorney who brought one of the lawsuits against the state, said the state decided to act in good faith. He said questions remain about whether or not there is even a health crisis. He said it was unfair to single out a small slice of the population upon which to force an untested vaccination.

"I think they tried to sneak this one under the radar," Kindlon said. "The lesson is it's better to play by the rule book."

Kindlon said he believes the decision to back off the mandate will end his court case, but some nurses want to prevent any future mandates, which the governor's office left open as a possibility.

Sue Field, a Poughkeepsie nurse who filed suit against the rule, said she wants to continue her case in order to get a court decision against the mandatory vaccine.

"This is encouraging, but I don't see that at this moment it would stop the lawsuit," she said.

| edit post

source: theflucase

Fears of the threat of martial law being implemented in the coming weeks in France are growing after the start of the mass "swine flu" vaccination campaign yesterday.

French group SOS Justice says that the organisation of the "swine flu" vaccination campaign has been shaped to increase the chances of the successful implementation of military rule.

The mass "swine flu" vaccination operation has been organised to fit the country's seven defence zones, set up to allow martial law to be imposed swiftly in the event of a national emergency such as a pandemic.

The zones -- similar to the FEMA regions in the USA -- are Bordeaux, Lille, Lyon, Marseille, Metz, Paris and Rennes.

A document from 2006, says that the military will be able to close borders, shut down schools and stop public assemblies among other martial law style measures in the event of a national emergency such as a pandemic.

Furthermore, the same document contained plans for dealing with mass fatalities, specifically, the need to identify mass graves.

A former director of CNRS, J-P Petit has said that the French army belonging to overseas territorities (DOM-TOM) has been told to prepare for mass forced vaccinations and to arrest protestors.

A French government document dated September 10th outlined plans for the compulsory vaccination of every single member of France's Gendamerie, a 100,000-strong military force charged with policing more rural parts of France.

The documents also foresaw the vaccination of all family members of the Gendamerie.

A report in Nice Matin dated October 16th indicated that the department Alpes Maritimes was planning to give the "swine flu" jab to every child at school without asking for parent's permission.

In the event of a pandemic level 6 emergency being declared by WHO -- as happened in June -- WHO is able to activate provisions in the International Health Regulations 2005 and the national pandemic plan in order to exercise authority over all public health and law enforcement services.

WHO is entitled to employ these "assets" to conduct forced quarantines and vaccinations.

This is a report by SOS Justice in French:

| edit post

source: theflucase

The news that a fourth person has died after taking the "swine flu" jab in Sweden is focussing attention on the failure of the Swedish Medical Products Agency (MPA) to halt the "swine flu" programme even as reports of serious side effects flood in.

The Swedish drug regulator has allowed the "swine flu" jab campaign to be launched even though there is no safety or efficacy data on the vaccine. GlaxoSmithKline's Pandemrix with mercury and squalene has been given approval under new and lax European Union regulations formulated by the European Medicines Agency, (EMEA) for a "pandemic emergency" that do not require safety or efficacy data.

The EMEA derives three-quarters of its funding from pharmaceutical companies.

The "swine flu" jab has been authorised for use only on condition that governments and companies implement "post-authorisation" studies to check it is safe and effective. However, the MPA in Sweden appears to have limited its role in collecting data on death and damage to spontaneous reports from doctors and patients.

In addition, there appears to be no accurate data available on how many people have been given the "swine flu" jab in Sweden.

The MPA has said it has no such data and the SMI has said that its system for collecting data on vaccines is flawed.

EU's own guidelines on "post authorisation" studies highlight the need to collect accurate data on "vaccine exposure".

"The basis for the assessment of an association between A/H1N1 influenza vaccines and severe adverse events should be Observed-to-Expected analyses. For this purpose, data will be needed on vaccine exposure and the expected number of cases. It is therefore crucial that background incidence rates on AESIs are collected as early as possible, before the vaccine is introduced on the market. Vaccine manufacturers should actively liaise with public health and regulatory authorities in countries where its vaccine(s) will be used in order to explore the availability of such data. Use of large electronic databases could be used if available. If data are not available, they could be extrapolated from other countries. Background incidence rates should be provided with any specific signal evaluation. "

MPA officials have given their view in the media that the deaths of Swedes directly after the "jab" were not linked to the "swine flu" vaccine but due to underlying medical condictions. Just how independent and effective will their investigation be if they are making this statement before conducting any inquiry or without adequate data?

Gunilla Sjölin-Forsberg from the MPA said in an email that the MPA was fulfilling all its requirements under the EMEA recommendations. She also revealed that there will be no study on the "swine flu" jab in Sweden. The only study on Pamdemrix will be carried out in the UK.

However, the question that needs to be to asked is whether there are personnel and financial links between the MPA officials and pharmaceutical companies. Have private or financial interests among MPA officials motivated them to allowed a drug classified as a bioweapon to come onto the market and to collude with pharmaceutical companies to evade responsibility for the harm this drug does to others by bending the regulations.

As a result of the gross negligence at a minimum of the MPA officials, millions of Swedes, especially children and maternity cases, are being exposed to death and damage from this jab.

These MPA officials must be held accountable.

This is Sjolin-Forsberg's email:

"MPA has implemented all parts of the EMEA recommendations for agencies concerning the pharmacovigilance plan. Spontaneous reporting is encouraged and a standardized reporting form published on our website. Cases of adverse events of special interest are specifically searched for and  we also receive reports directly from consumers.

To further clarify: the MPA has implemented all parts of the EMEA recommendations for agencies concerning the pharmacovigilance plan. Spontaneous reporting is encouraged and a standardized reporting form published on our website. Cases of adverse events of special interest are specifically searched for and  we also receive reports directly from consumers. As for post-authorisation studies the EMEA request is that the MAH (marketing authorization holder) puts in place a prospective cohort study  in at least one European Member state. This will be done in UK and for more information I suggest you contact the MHRA. These described actions summarizes the recommendations from EMEA.

In addition to this, a Swedish registry study is being implemented covering a significant portion of vaccinated people.

CHMP Recommendations for the Pharmacovigilance Plan as part of the Risk Management Plan to be submitted with the Marketing Authorisation Application for a Pandemic Influenza Vaccine

Adopted by CHMP in November 2006

Revision 1.0 adopted by CHMP on 25 June 2009

Revision 1.1 adopted by CHMP on 24 September 2009


The CHMP Guideline on dossier structure and content for pandemic influenza vaccine marketing authorisation application (CPMP/VEG/4717/03) specifies that, as part of the post-approval commitments, Marketing Authorisation Holders (MAHs) should have protocols in place at the time of authorisation of the mock-up vaccine to ensure that immunogenicity, effectiveness and safety of the final pandemic vaccine are adequately documented during use in the field (i.e. during the pandemic), since there will be only limited immunogenicity and safety data and no efficacy data at the time of licensing.

iv) The basis for the assessment of an association between A/H1N1 influenza vaccines and severe adverse events should be Observed-to-Expected analyses. For this purpose, data will be needed on vaccine exposure and the expected number of cases. It is therefore crucial that background incidence rates on AESIs are collected as early as possible, before the vaccine is introduced on the market. Vaccine manufacturers should actively liaise with public health and regulatory authorities in countries where its vaccine(s) will be used in order to explore the availability of such data. Use of large electronic databases could be used if available. If data are not available, they could be extrapolated from other countries. Background incidence rates should be provided with any specific signal evaluation.

4.5. Post-Authorisation Safety Study

Very limited knowledge on safety will be available from A/H1N1 influenza vaccines before use. Additional pharmacovigilance activities for the vaccines used during pandemic are therefore needed to assess safety. Given differences in the vaccination policy between member states in terms of type of vaccine used, target population prioritised for vaccination, setting of vaccination and surveillance systems already in place, it is considered that a single method cannot be proposed.

A minimum requirement is that each MAH puts in place a prospective cohort study for each vaccine, for which specifications are described below. The design of the prospective cohort study of exposed subjects and of other additional pharmacovigilance activities should be presented in the risk management plan.

| edit post

Interview with Barb Loe Fisher, Founder of the National Vaccine Information Center (split into 6 parts). Click here to watch the rest.

Part 1

Part 2

Part 3

Part 4

Part 5

Part 6

| edit post


Summer is over and the question I am being asked most frequently in my practice is, “what do I do about Swine flu?” My patients are wondering whether or not they should get vaccinated and the simple answer I give most of the time is ..NO!

From what you may have read, you might think that the swine flu vaccine is the answer to swine flu. Unfortunately this is not true and until we know that the vaccine is safe, I cannot in good conscience recommend it to most of my patients.

From the outset, let me say, I am not anti all vaccinations, rather I am pro vaccine safety and freedom of choice.

This is why am I not recommending the swine flu vaccine:

1. At this stage, for the most part the swine flu seems benign.

Over a million people in the US have already come down with swine flu, many of them without even knowing that they had it. The vast majority of people who get the swine flu recover after a week or so of high fever, aches, and respiratory distress. It’s not pleasant, but except in rare circumstances, it is not fatal. Most people who’ve been infected by swine flu think so little of it, they believe they just had a really bad cold or a regular flu. So unless the swine flu evolves to a much more virulent form, there’s no need for mass vaccination.

2. We don’t know if the vaccine will be effective.

Vaccines are only useful against the specific viral strain that was available at the time of their manufacture. But influenza viruses mutate quickly, and as the WHO has already said, the real concern with H1N1 swine flu is that it will combine with seasonal flu in the Fall, creating a new strain that will of course be immune to all available vaccines.

3. We don’t know if the vaccine is safe.

The FDA has authorized an expedited approval process for the swine flu vaccine, but we don’t know yet if it is safe. Even GlaxoSmithKline, one of the vaccine manufacturers has said, “The total population studied in clinical trials will be limited, due to the need to provide the vaccine to governments as quickly as possible. Additional studies will therefore be required and conducted after the vaccine is made available.”

In other words, the only thing that is safe, is to say that no one knows. Since it’s never been used before and they have not had time to conduct any sufficient human testing, by getting vaccinated you are being a human guinea pig.

4. Vaccine manufacturers have been insulated from liability by the government.

The Department of Health and Human Services Secretary Kathleen Sibelius has granted legal immunity not only to the makers of the two drugs being used to treat swine flu, Tamiflu and Relenza, but also to the swine flu vaccine makers, for damages due to their use against swine flu. By effectively manipulating the legal system, the Pharmaceutical Industry through their powerful lobbyists have acquired almost complete and total insulation from any liability for their vaccines and adjuvants, which are additives added to generate a stronger immune response. It is believed that it is these adjuvants which often cause the problems. The last time the government embarked on a major vaccine campaign against a new swine flu was in 1976. Thousands filed claims for side effects such as paralysis caused by the vaccine and a number of people died. I am sure that the researchers know more now than they did last time and no one can say for certain that bad things will happen again or that you will suffer dire consequences if you get vaccinated. But this time you have no legal recourse even though this vaccine involves new factors, which makes it therefore experimental and unpredictable.

By shielding the manufacturers from any responsibility for any harm caused, the pharmaceutical firms have no financial incentive to make the safest product. In fact, they have a negative incentive to test it for safety, because if they are aware of problems, then they could potentially be held liable for willful misconduct.

Instead I advise my patients to build up and strengthen their immune systems to prevent viral infections.

| edit post


The pharmaceutical industry, with public health officials and the mainstream media acting as a mass marketing team, is about to pull off the biggest profiteering scheme in the history of the world. The swine flu hoax, perpetrated on a global level, will generate unheard of profits from a non-existent pandemic.

The Obama administration declared the spread of swine flu a public health emergency on April 26, 2009. The Associated Press reported that "Swine flu is now formally a pandemic, a declaration by U.N. health officials that will speed vaccine production and spur government spending to combat the first global flu epidemic in 41 years," on June 11, 2009.

"WHO chief Dr. Margaret Chan made the long-awaited declaration after the U.N. agency held an emergency meeting with flu experts and said she was moving to phase 6 -- the agency's highest alert level -- which means a pandemic is under way," the AP advised.

Since the "highest alert" warning was issued, the only estimation that has turned out to be true is that the drug companies are experiencing a windfall of tax dollars pouring into their coffers.

The US government "has committed $1.8 billion to companies to make a swine flu vaccine," Reuters reported on September 30, 2009, in an article with the headline, "Big pharma jumps back into flu business."

"Three big U.S. pharmaceutical companies announced vaccine deals this week," Reuters noted, for companies that included Johnson & Johnson, Abbott Laboratories and Merck.

"Abbott Labs bought a Belgian drug business, along with its flu vaccine facilities, for $6.6 billion. Johnson & Johnson invested $444 million in a Dutch biotech firm (Crucell) that makes and develops flu vaccines. Merck which already makes vaccines for shingles and other diseases, struck a deal to distribute flu shots made by Australian CSL," ABC News reported on October 14, 2009

"Smaller biotechs are also angling for a slice of the action, making vaccines one of the fastest-growing areas of research in the biotech industry," ABC noted.

Dr Robert Belshe, director of Saint Louis University's Center for Vaccine Development, told Reuters that the US is on the verge of recommending that all citizens get a flu shot. "We're at 270 million people who should get vaccinated. It's a big market. I think manufacturers are just now catching up," he said.

"The vaccine market is booming. It's an enormous growth area for pharmaceuticals at a time when other areas are not doing so well," Bruce Carlson, a spokesperson for the market research firm Kalorama, told ABC News.

On October 1, 2009, under the headline, "Vical shares soar on Navy's H1N1 contract," Fierce Vaccines advised that: "Anyone doubting just how hot H1N1 news is right now should check out Vical's stock price this morning."

"The developer announced a modest $1.3 million contract with the Navy to fund the manufacturing and testing of its swine flu vaccine and the company's stock shot up 22 percent," the report said.

On September 29, 2009, Reuters noted that the H1N1 flu pandemic is not "the first flu outbreak to have lifted the shares of small vaccine makers."

"The H5N1 bird flu scare that began in 2005 fueled a similar rise," the reports said. "And the media statements issued by companies then are similar to many of those issued today."

"In May 2006, Vical, for example, announced that its bird flu vaccine protected mice and ferrets against H5N1," Reuters recalled.

"This year, it said its H1N1 pandemic flu vaccine protected rabbits and mice. The news sent its shares soaring," the report noted.

Vaccine Makers Fund Studies
On September 10, 2009, MedPage Today ran the headline: "H1N1 Vaccines Safe, Immunogenic in Single Dose".

"Two investigational vaccines against the pandemic H1N1 flu appear to be safe and to yield a robust immune response with a single dose," MedPage reported.

"Those findings," it said, "contained in two preliminary reports published online today in the New England Journal of Medicine -- are reassuring, experts said."

The first report is from an Australian study supported by CSL and the Department of Health and Aging of the Australian government. "All authors report being employees of CSL and several report having an equity interest in the company," according to MedPage.

The second report is from a British study supported by University Hospitals Leicester and Novartis. Study leader, Dr Iain Stephenson, "reported financial links with Novartis Vaccines, Sanofi Pasteur, Baxter Vaccines, Hoffmann–La Roche, and GlaxoSmithKline," MedPage noted.

Profits Galore
On September 21, 2009, Reuters reported that the United States had ordered 222 million doses of H1N1 vaccine from five drug makers that include GlaxoSmithKline, Sanofi-Pasteur, Australia's CSL, AstraZeneca's MedImmune division and Novartis.

CSL has contracts to supply $180 million worth of bulk antigen to the US. Sanofi-Pasteur is providing more than 100 million doses to the US, in a $690 million order.

On September 25, 2009, MedImmune said it has "received a federal order for 29 million more doses of its nasal H1N1 flu vaccine, bringing its total order to more than 40 million doses, with a value of about $453 million," according to

Seeking Alpha reported on August 24, 2009, that the "Swiss company Novartis received an order for $346 million for antigen and $343.8 million for adjuvant totalling $690 million in July."

The most recent estimates have GlaxoSmithKline "reaping some $4.8 billion from the pandemic, between its Pandemrix vaccine, its Relenza antiviral drug, and other products such as antiviral face masks and flu diagnostics," Fierce Pharma reported on October 9, 2009.

On June 11, 2009, Kalorama Information issued a press release with the headline, "New Report Forecasts More Than Doubling of Vaccine Sales by 2013."

The new report titled, "Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry," forecasts the market "to more than double by 2013 due to a strong pipeline of new products and rising usage of current products around the world," Kalorama wrote.

In the press release, Kalorama described 2008 as another "stellar year for the world vaccine market," in which sales "grew 21.5% since 2007 to reach $19.2 billion."

"Few areas of pharmaceuticals have seen the fast-moving developments in the marketplace that the vaccine market has," Kalorama noted.

Antiviral Drug Hype
On October 15, 2009, the Financial Times ran the headline: "Tamiflu boosts Roche sales figures," and reported that sales figures "were boosted by bumper demand for Tamiflu amid persistent fears about a global flu pandemic."

Tamiflu sales of $1.9 billion in the first nine months were more than four times ahead of the same period last year and third quarter sales figures were "nearly 10 times more than in the same period last year."

On July 22, 2009, Business Week reported that GlaxoSmithKline "expects to increase annual production of its inhalable anti-viral flu treatment Relenza threefold, to 190 million doses, by year end."

"Relenza sales for the three months ended June 30 were $99 million, up from just $5 million in the second quarter of 2008," the report noted.

The price of Tamiflu at a middle dose at on August 26, 2009, was $93 for a packet of ten 75mg capsules. One inhaler of Relenza costs $64 at

Any good that will come from the swine flu propaganda campaign will accumulate solely with the profits of pharmaceutical industry.

| edit post

Swine Flu madness

Posted by wicked blu 0 comments

Under federal laws adopted post 9/11, the Secretary of HHS can declare a national emergency and order all citizens to be vaccinated.These extreme powers can permit agents of the federal government to enter private residences to compel those inside to receive vaccinations.
Jonathan W. Emord - Attorney of constitutional and administrative law

More than a third of parents don't want their kids vaccinated, according to an Associated Press-GfK poll yet public health officials seem ready to ram it down their throats if possible. Parents say they are concerned about side effects from the new vaccine and many say swine flu doesn't amount to any greater health threat than seasonal flu. The AP poll found that 38 percent of parents said they were unlikely to give permission for their kids to be vaccinated at school. The AP poll, conducted Oct. 1-5, found 72 percent of those surveyed are worried about side effects.

Health and Human Services Secretary Kathleen Sebelius appealed for widespread inoculation against swine flu, vouching unconditionally for the vaccine: "We know it's safe and secure." This official has what can only be considered as Swine Flu Madness for she really does not know if it’s safe and secure. In fact she has to know that a warning that the new swine flu jab is linked to a deadly nerve disease has been sent by the Government to senior neurologists in a confidential letter. The letter from the Health Protection Agency, the official body that oversees public health tells the neurologists that they must be alert for an increase in a brain disorder called Guillain-Barre Syndrome (GBS), which could be triggered by the vaccine. GBS attacks the lining of the nerves, causing paralysis and inability to breathe, and can be fatal. The letter, sent to about 600 neurologists on July 29,4 is the first sign that there is concern at the highest levels that the vaccine itself could cause serious complications yet Sebelius and others are on their bullhorns telling the public it is safe.

More than half a million U.S. children yearly have bad reactions or side effects from widely used medicines that require medical treatment and sometimes hospitalization.

U.S. health officials have lost track of how many illnesses and deaths have been caused by the first global flu epidemic in 40 years. And they did it on purpose. Government doctors stopped counting swine flu cases in July. Yet at the same time we find at a recent CDC weekly meeting on swine flu, Anne Schuchat, MD, Director of the CDC’s National Centre for Immunization and Respiratory Diseases, informed of the increasing illnesses, hospitalizations, and deaths, virtually all due to the H1N1 virus. To date, 37-states have reported cases of swine flu, with 19-paediatric deaths reported last week, which means 76-children have died of swine flu this year, many more than the typical influenza toll in the past years. According to CDC, between 30th August and 3rd October, 1,784-American adults and children have died from pneumonia or different strains of influenza.7 Health officials seem to be confused; are they counting or not?

Fortunately we have some heroes standing up to the might of the vaccine industry and public health officials. Mike Adams over at Natural News reports that health freedom attorney Jim Turner is filing a lawsuit in Washington D.C. mid-day Friday in an urgent effort to halt the distribution of the swine flu vaccine in America. On behalf of plaintiffs Dr. Gary Null and other licensed health care workers of New York State, the lawsuit charges that the FDA violated the law in its hasty approval of four swine flu vaccines by failing to scientifically determine neither the safety nor efficacy of the vaccines. "The suit will seek an injunction against the FDA from approving the vaccine and the core of the argument is that they have not done the proper safety and efficacy tests on the vaccine to allow it to be released at this time," attorney Jim Turner told Natural News.

The World Health Organization (WHO) restated its confidence in the H1N1 flu vaccine on October 6th, calling it the most important tool against the pandemic though they admit that mild adverse side effects such as muscle cramps or headache are to be expected in some cases, but everyone who has access to the vaccine should be inoculated the WHO said. Of course they don’t mention the possibility of serious side effects including death.

As soon as swine flu vaccinations start next month, some people getting them will drop dead of heart attacks or strokes, some children will have seizures and some pregnant women will miscarry.
New York Times
September 28, 2009

A majority of doctors and medical examiners are notoriously prone to gloss over the official cause of death when mortality occurs in close proximity to vaccine administration. It is not surprising that the WHO recommends the vaccine even to pregnant women for the WHO is a front organization for one world government, which obviously could care less if fetuses are contaminated. Officials are worried about spontaneous miscarriages, because they are urging pregnant women to be among the first to be vaccinated even though most of the vaccines contain thimerosal, which is fifty percent methyl mercury by weight.

Any competent biochemist would look at the structure of thimerosal and identify it as a potent enzyme inhibitor.
What is surprising is that the appropriate animal and laboratory testing was not done on the vaccines containing thimerosal (and aluminum)before the government embarked on a mandated vaccine program that exposed infants to the levels of thimerosal that occurred - Dr. Boyd E. Haley

Yet today we find the New York Times giving space to Dr. Paul A. Offit who says, “Infants could safely receive eight times as much mercury as is contained in the H1N1 vaccine.”9 Dr. Haley, former chairman of the chemistry department of Kentucky University is one of the most intelligent and noble men I have ever had the pleasure to talk to. One can hardly say that about Offit who has financial stakes in the vaccine industry.10

Why would you sign a consent form for your children to be injected with mercury, which is 100 times more brain-toxic than lead? And why would your government want you to do so? Pregnant women and their fetuses are especially sensitive to mercury and mercury has been established by the federal vaccine court to be associated with autism in cases where the children had mitochondrial disease. Problem is doctors and nurses have not the slightest idea which children have such metabolic disorder before they inject their little patients with so many vaccines it would turn grandma’s hair white if it wasn’t already.

Documents from the archives of Eli Lilly & Company clearly demonstrate that it was known as early as April 1930 that the thimerosal was dangerous.

The following is a list of some of the nasty side effects that the package insert for the Influenza A (H1N1) 2009 Monovalent Vaccine manufactured by Novartis admits to:11

*Local injection site reactions (including pain, pain limiting limb movement, redness, swelling, warmth, ecchymosis, induration)
*Hot flashes/flushes
*Facial edema.
*Immune system disorders
*Hypersensitivity reactions (including throat and/or mouth edema)
*In rare cases, hypersensitivity reactions have lead to anaphylactic shock and death
*Cardiovascular disorders
*Vasculitis (in rare cases with transient renal involvement)
*Syncope shortly after vaccination
*Digestive disorders
*Abdominal pain.
*Blood and lymphatic disorders
*Local lymphadenopathy
*Transient thrombocytopenia.
*Metabolic and nutritional disorders
*Loss of appetite.
*Nervous system disorders
*Febrile convulsions
*Guillain-Barré Syndrome
*Myelitis (including encephalomyelitis and transverse myelitis)
*Neuropathy (including neuritis)
*Paralysis (including Bell’s Palsy)
*Respiratory disorders
*Chest pain
*Stevens-Johnson syndrome
*Rash (including non-specific, maculopapular, and vesiculobulbous).

GlaxoSmithKline won a further 22 government orders for its H1N1 swine flu vaccine in the last two months, taking the total number of doses ordered to 440 million worth some $3.5 billion. Rivals in flu vaccines include Sanofi-Aventis, Novartis, Baxter, AstraZeneca and CSL. The President's Council of Advisors anticipates that 2009 H1N1 may infect half of the US population, require 1.8 million hospitalizations, and result in 30,000-90,000 deaths12 but it is not clear whether the virus or the vaccines themselves will be the major cause of what they are anticipating. Considering the fact that the swine flu has been very mild we can easily believe that the vaccines themselves will do the dirty work.

I have run against so many histories of little children who had never seen a sick day until they were vaccinated and who,in the several years that have followed, have never seen a well day since.

*I couldn’t put my finger on the disease they have.
*They just weren’t strong. Their resistance was gone.
*They were perfectly well before they were vaccinated.
*They have never been well since.

Dr. William Howard Hay

Dr. Hay is not alone and its public knowledge that tens of thousands of health care workers typically avoid flu shots because of questions of safety and effectiveness. Fewer than half of them got flu vaccinations last year, according to a Centers for Disease Control and Prevention survey. That includes physicians in clinics, lab technicians, respiratory therapists and home health aides.

Approximately one-half of the hundreds of parents who call our office each month report that their child became autistic shortly after receiving a vaccination.
Portia Iverson
Cure Autism Now foundation in Los Angeles

The official advice on swine flu protection is essentially limited to "wash your hands, get your vaccine shot and cough into your elbow. The omission of vitamin D (among many other things) is another demonstration of pharmaceutical and medical terrorism. The officials we pay and trust could care less if we die from the flu or flu shot, in fact our deaths substantiate their theories and marketing campaigns. The simple addition of vitamin D supplementation or recommendations to get healthy doses of sun and vitamin C would go a long way, longer than the vaccines to mitigate death from the flu. So would recommendations to doctors and patients to fully hydrate. Yesterday I received a testimonial13 of the use of hydrogen peroxide and in addition to the IMVA protocol14 for Swine Flu treatments.

Utter Criminal Madness to Use Thimerosal in Vaccines

Robert F. Kennedy Jr. published in the Huffington Post a few years ago devastating evidence that implicated the CDC in a terrible scandal in regards to the unnecessary injection of millions of children with thimerosal a few years back and this is important because again the CDC is going to allow mercury containing thimerosal to be used in the swine flu shots as well as the regular flu shots in the fall of 2009.

Correspondence obtained under the Freedom of Information Act reveals a medical monstrosity at the very center of the medical world. Soon after the CDC in July 1999 recommended that the nation's vaccine makers eliminate Thimerosal as a preservative, "as soon as possible," they themselves (the CDC) secretly discouraged Thimerosal removal in effect deliberately exposing millions of infants to continued mercury poisoning.

According to Kennedy, in a July 1999 letter, vaccine producer SmithKline Beecham tells CDC that it is ready to produce non-Thimerosal DTP (Diptheria/Tetanus/Pertussis) vaccines immediately and has sufficient inventories to supply the entire U.S. market during the remainder of 1999 and the first half of 2000, by which time other vaccine manufacturers would have their Thimerosal-free DTP vaccines on line. Thimerosal-laden DTP vaccines containing 25 micrograms of mercury apiece (75 thousand trillion atoms of mercury) were then being administered to American infants at two months, four months and six months -- far exceeding EPA's recommended safe level for mercury. Had CDC accepted SmithKline's offer, it could have immediately reduced the mercury exposures to vaccinated six-month-old children by 40%.

Kennedy continued, “However, in November, CDC mysteriously sent a letter back rejecting SmithKline's offer. Then, on July 14, 2000 CDC published a deceptive press release promising to require that all vaccines be Thimerosal-free as soon as "adequate supplies are available." This was a full 12 months after the agency had denied SmithKline's proposal.”

I devoted time to study this issue because I believe that this is a moral crisis that must be addressed. If, as the evidence suggests, our public-health authorities knowingly allowed the pharmaceutical industry to poison an entire generation of American children, their actions arguably constitute one of the biggest scandals in the annals of American medicine.
Robert F. Kennedy, Jr.

"If CDC were basing its decision on safety alone, it would have taken SmithKline up on its offer. That's a no-brainer," said a federal health official to Kennedy anonymously. "So there were other considerations beside safety that were guiding their decision making." “Among these "other considerations" were CDC's important concerns for the preservation of the vaccine program, a bureaucratic impulse for self-preservation, and protecting the economic interests of its vaccine industry friends."Immediate withdrawal would send a strong message; 'We messed up!'" the health official told Kennedy. "And I don't think they wanted to send that message to parents, the public or those considering legal action." "There was also concern," says the federal official, "that an immediate withdrawal might discredit the international vaccine programs for which CDC is an important partner."

Why will CDC inject millions of minority kids in America's poorest neighborhoods with poison proven to kill brain tissue and cause learning disorders when child-safe vaccines are available?
Robert F. Kennedy Jr.

Mark Sircus Ac., OMD
Director International Medical Veritas Association

| edit post


Thank you for visiting 'Do Not Inject Me'

The purpose of this site is to bring to your attention the dangers of all vaccines, pharmaceutical drugs and some of the severe effects they can have on you as a human being.

Along the way we hope to provide you with health articles regarding alternative and natural remedies, and that you find the information presented here a great resource in empowering you to become a more active and healthier being.

Say No!

Say No!

Natural News

Dr. Mercola

Vac Truth

Christina England